[Effects in humans of a new beta adrenergic receptor blocking agent on tachycardia induced with isoprenaline].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D004336:Drug Antagonism; D006321:Heart / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D009284:Naphthols / Q000494:pharmacology / Q000627:therapeutic use; D011412:Propanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D013610:Tachycardia / Q000139:chemically induced / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D009284:Naphthols; D011412:Propanolamines; D007545:Isoproterenol
Effetti nelluomo di un nuovo farmaco blocante i recettori adrenergici beta sulla tachicardia da isoprenalina.